SCHEMBL7082772

SCHEMBL7082772

CC(=O)c1ccc(N(C)C)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 2/20 0.45
ALDH1A1 P00352 6/20 0.44
KCNJ1 P48048 1/20 0.42
MAPT P10636 4/20 0.42
HPGD P15428 2/20 0.42
RAB9A P51151 5/20 0.42
NPC1 O15118 4/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPK1 P28482 2/20 0.42
MCL1 Q07820 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978302 0.84 P4HTM (0.60) P4HTMALDH1A1MAPTHPGDNPC1
SCHEMBL28247848 0.82 KMT2A (0.49) P4HTMALDH1A1MAPTHPGDRAB9A
SCHEMBL10473068 0.79 MAPK1 (0.61) P4HTMALDH1A1MAPTHPGDRAB9A
SCHEMBL19387743 0.77 KCNH2 (0.39) P4HTMALDH1A1MAPTHPGDRAB9A
SCHEMBL7139611 0.77 P4HTM (0.40) P4HTMALDH1A1MAPTHPGDRAB9A
SCHEMBL4303236 0.74 ALDH1A1 (0.43) P4HTMALDH1A1MAPTHPGDRAB9A
SCHEMBL9109279 0.74 PRMT1 (0.41) P4HTMALDH1A1MAPTKDM4EMAPK1
SCHEMBL30443990 0.74 ALDH1A1 (0.50) P4HTMALDH1A1KCNJ1KDM4EMAPK1
SCHEMBL20367726 0.73 KCNJ1 (0.35) P4HTMALDH1A1KCNJ1
SCHEMBL8139255 0.73 CDK4 (0.41) ALDH1A1KCNJ1HPGDKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed
EP-1196384-A4 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO INC (US) 2002-10-23 EP disclosed
EP-1196384-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF Merck & Co., Inc. (US) 2002-04-17 EP disclosed
WO-2001000578-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO., INC. (US) 2001-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 P4HTM 915/4885ALDH1A1 145/4885KCNJ1 2410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.